Alanine

Alanine

SCHEMBL2164078

CC(N)C(=O)O.CC1CC1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 0.43
EPHX1 P07099 1/20 0.42
TP53 P04637 1/20 0.38
SLC1A2 P43004 3/20 0.38
SLC1A1 P43005 3/20 0.38
GRM2 Q14416 2/20 0.38
GRM3 Q14832 2/20 0.38
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
GRM8 O00222 1/20 0.34
GRM6 O15303 1/20 0.34
LMNA P02545 1/20 0.34
APEX1 P27695 1/20 0.34
GRM5 P41594 1/20 0.34
PMP22 Q01453 1/20 0.34
GRM1 Q13255 1/20 0.34
GRM4 Q14833 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alanine SCHEMBL28361274 0.83 SLC7A5 (0.43) SLC7A5TP53SLC1A2SLC1A1GRM2
SCHEMBL2163519 0.83 TP53 (0.38) SLC7A5EPHX1TP53SLC1A2SLC1A1
Valine SCHEMBL719594 0.82 SLC7A5 (0.71) SLC7A5EPHX1SLC1A2SLC1A1
Alanine SCHEMBL14764702 0.82 SLC7A5 (0.59) SLC7A5TP53SLC1A2SLC1A1ALDH1A1
Alanine SCHEMBL1332110 0.82
Alanine SCHEMBL31 0.82
Alanine SCHEMBL2784274 0.82
D-Alanine SCHEMBL614024 0.82 SLC7A5 (0.59) SLC7A5TP53SLC1A2SLC1A1ALDH1A1
Alanine SCHEMBL452350 0.82 SLC7A5 (0.59) SLC7A5TP53SLC1A2SLC1A1ALDH1A1
Alanine SCHEMBL254290 0.82 SLC7A5 (0.59) SLC7A5TP53SLC1A2SLC1A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7985762-B2 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-07-26 US disclosed
US-20110165120-A1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110165120-A1 INHIBITORS OF SERINE PROTEASES PRSS1, PRSS3, PRSS2 SLC7A5 1123/4885EPHX1 1666/4885TP53 396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.